Notice of Issuance of Regulatory Guide, 39994 [E8-15794]

Download as PDF 39994 Federal Register / Vol. 73, No. 134 / Friday, July 11, 2008 / Notices regulatory requirements of 10 CFR Part 33. Volume 11 of NUREG–1556 is not intended to be used alone. Because broad-scope licensees may be involved in many different program areas (e.g., medicine, research and development, manufacturing and distribution), Volume 11 frequently refers the user to other more program-specific guidance documents in the NUREG–1556 series. A single document containing all of the guidance that might be required by a broad-scope licensee or an applicant for a broad-scope license would be unwieldy and may become obsolete as guidance in the individual program areas is revised. Volume 11 of NUREG– 1556 takes a more risk-informed, performance-based approach to the information needed to support an application for a specific license of broad scope. Applicants should consider the entire NUREG–1556 series when preparing broad-scope license applications. NRC staff will use applicable portions of the complete NUREG–1556 series when reviewing applications. II. Further Information pwalker on PROD1PC71 with NOTICES In January 2008, DG–0015 was published with a public comment period of 60 days from the issuance of the guide. No comments were received and the public comment period closed on April 18, 2008. Electronic copies of Regulatory Guide 10.5, Revision 2 are available through the NRC’s public Web site under ‘‘Regulatory Guides’’ at https://www.nrc.gov/reading-rm/doccollections/. In addition, regulatory guides are available for inspection at the NRC’s Public Document Room (PDR), which is located at Room O–1F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852–2738. The PDR’s mailing address is USNRC PDR, Washington, DC 20555–0001. The PDR can also be reached by telephone at (301) 415–4737 or (800) 397–4209, by fax at (301) 415–3548, and by e-mail to pdr@nrc.gov. Regulatory guides are not copyrighted, and NRC approval is not required to reproduce them. Dated at Rockville, Maryland, this 3rd day of July, 2008. For the Nuclear Regulatory Commission. Stephen C. O’Connor, Acting Chief, Regulatory Guide Development Branch, Division of Engineering, Office of Nuclear Regulatory Research. [FR Doc. E8–15788 Filed 7–10–08; 8:45 am] BILLING CODE 7590–01–P VerDate Aug<31>2005 17:19 Jul 10, 2008 Jkt 214001 NUCLEAR REGULATORY COMMISSION Notice of Issuance of Regulatory Guide Nuclear Regulatory Commission. ACTION: Notice of Issuance and Availability of Regulatory Guide 6.1, Revision 2. AGENCY: FOR FURTHER INFORMATION CONTACT: Mark Orr, Regulatory Guide Development Branch, Division of Engineering, Office of Nuclear Regulatory Research, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001, telephone (301) 415– 6373 or e-mail to Mark.Orr@nrc.gov. SUPPLEMENTARY INFORMATION: I. Introduction The U.S. Nuclear Regulatory Commission (NRC) has issued revisions to existing guides in the agency’s ‘‘Regulatory Guide’’ series. This series was developed to describe and make available to the public information such as methods that are acceptable to the NRC staff for implementing specific parts of the agency’s regulations, techniques that the staff uses in evaluating specific problems or postulated accidents, and data that the staff needs in its review of applications for permits and licenses. Revision 2 of Regulatory Guide 6.1, ‘‘Leak Testing Radioactive Brachytherapy Sources,’’ was issued with a temporary identification as Draft Regulatory Guide DG–6003. This guide directs the reader to methods and procedures acceptable to the staff of the NRC for leak testing radioactive brachytherapy sources. Possession and use of brachytherapy sources is an activity requiring a license pursuant to Title 10, section 30.3, ‘‘Activities Requiring License,’’ of the Code of Federal Regulations (10 CFR 30.3). The requirements in 10 CFR 35.67, ‘‘Requirements for Possession of Sealed Sources and Brachytherapy Sources,’’ state in part, that the sources are to be periodically leak tested and that the test be capable of detecting the presence of 185 becquerel (Bq) (0.005 microcurie (µCi)) of radioactive material in the sample. The regulations also require that the source be immediately withdrawn from use if the test reveals the presence of 185 Bq (0.005 µCi) or more of removable contamination. This regulatory guide endorses the methods and procedures for leak testing radioactive brachytherapy sources contained in the current revisions of NUREG–1556, Volume 3, ‘‘Consolidated Guidance about Materials Licenses: PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 Applications for Sealed Source and Device Evaluation and Registration’’ and NUREG–1556, Volume 9, ‘‘Consolidated Guidance about Materials Licenses: Program-Specific Guidance about Medical Use Licenses’’ as a process that the NRC staff has found to be acceptable for meeting the regulatory requirements. II. Further Information In January 2008, DG–6003 was published with a public comment period of 60 days from the issuance of the guide. No comments were received and the public comment period closed April 18, 2008. Electronic copies of Regulatory Guide 6.1, Revision 2 are available through the NRC’s public Web site under ‘‘Regulatory Guides’’ at https://www.nrc.gov/reading-rm/doccollections/. In addition, regulatory guides are available for inspection at the NRC’s Public Document Room (PDR), which is located at Room O–1F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852–2738. The PDR’s mailing address is USNRC PDR, Washington, DC 20555–0001. The PDR can also be reached by telephone at (301) 415–4737 or (800) 397–4209, by fax at (301) 415–3548, and by e-mail to pdr@nrc.gov. Regulatory guides are not copyrighted, and NRC approval is not required to reproduce them. Dated at Rockville, Maryland, this 3rd day of July, 2008. For the Nuclear Regulatory Commission. Stephen C. O’Connor, Acting Chief, Regulatory Guide Development Branch, Division of Engineering, Office of Nuclear Regulatory Research. [FR Doc. E8–15794 Filed 7–10–08; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Notice of Issuance of Regulatory Guide Nuclear Regulatory Commission. AGENCY: Notice of Issuance and Availability of Regulatory Guide 10.2, Revision 2. ACTION: FOR FURTHER INFORMATION CONTACT: Mark Orr, Regulatory Guide Development Branch, Division of Engineering, Office of Nuclear Regulatory Research, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001, telephone (301) 415– 6373 or e-mail to Mark.Orr@nrc.gov. SUPPLEMENTARY INFORMATION: E:\FR\FM\11JYN1.SGM 11JYN1

Agencies

[Federal Register Volume 73, Number 134 (Friday, July 11, 2008)]
[Notices]
[Page 39994]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-15794]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Notice of Issuance of Regulatory Guide

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of Issuance and Availability of Regulatory Guide 6.1, 
Revision 2.

-----------------------------------------------------------------------

FOR FURTHER INFORMATION CONTACT: Mark Orr, Regulatory Guide Development 
Branch, Division of Engineering, Office of Nuclear Regulatory Research, 
U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001, 
telephone (301) 415-6373 or e-mail to Mark.Orr@nrc.gov.

SUPPLEMENTARY INFORMATION:

I. Introduction

    The U.S. Nuclear Regulatory Commission (NRC) has issued revisions 
to existing guides in the agency's ``Regulatory Guide'' series. This 
series was developed to describe and make available to the public 
information such as methods that are acceptable to the NRC staff for 
implementing specific parts of the agency's regulations, techniques 
that the staff uses in evaluating specific problems or postulated 
accidents, and data that the staff needs in its review of applications 
for permits and licenses.
    Revision 2 of Regulatory Guide 6.1, ``Leak Testing Radioactive 
Brachytherapy Sources,'' was issued with a temporary identification as 
Draft Regulatory Guide DG-6003. This guide directs the reader to 
methods and procedures acceptable to the staff of the NRC for leak 
testing radioactive brachytherapy sources. Possession and use of 
brachytherapy sources is an activity requiring a license pursuant to 
Title 10, section 30.3, ``Activities Requiring License,'' of the Code 
of Federal Regulations (10 CFR 30.3). The requirements in 10 CFR 35.67, 
``Requirements for Possession of Sealed Sources and Brachytherapy 
Sources,'' state in part, that the sources are to be periodically leak 
tested and that the test be capable of detecting the presence of 185 
becquerel (Bq) (0.005 microcurie ([mu]Ci)) of radioactive material in 
the sample. The regulations also require that the source be immediately 
withdrawn from use if the test reveals the presence of 185 Bq (0.005 
[mu]Ci) or more of removable contamination.
    This regulatory guide endorses the methods and procedures for leak 
testing radioactive brachytherapy sources contained in the current 
revisions of NUREG-1556, Volume 3, ``Consolidated Guidance about 
Materials Licenses: Applications for Sealed Source and Device 
Evaluation and Registration'' and NUREG-1556, Volume 9, ``Consolidated 
Guidance about Materials Licenses: Program-Specific Guidance about 
Medical Use Licenses'' as a process that the NRC staff has found to be 
acceptable for meeting the regulatory requirements.

II. Further Information

    In January 2008, DG-6003 was published with a public comment period 
of 60 days from the issuance of the guide. No comments were received 
and the public comment period closed April 18, 2008. Electronic copies 
of Regulatory Guide 6.1, Revision 2 are available through the NRC's 
public Web site under ``Regulatory Guides'' at https://www.nrc.gov/
reading-rm/doc-collections/.
    In addition, regulatory guides are available for inspection at the 
NRC's Public Document Room (PDR), which is located at Room O-1F21, One 
White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852-
2738. The PDR's mailing address is USNRC PDR, Washington, DC 20555-
0001. The PDR can also be reached by telephone at (301) 415-4737 or 
(800) 397-4209, by fax at (301) 415-3548, and by e-mail to pdr@nrc.gov.
    Regulatory guides are not copyrighted, and NRC approval is not 
required to reproduce them.

    Dated at Rockville, Maryland, this 3rd day of July, 2008.

    For the Nuclear Regulatory Commission.
Stephen C. O'Connor,
Acting Chief, Regulatory Guide Development Branch, Division of 
Engineering, Office of Nuclear Regulatory Research.
[FR Doc. E8-15794 Filed 7-10-08; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.